Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Lauroyl-CoA)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Blood Mouse Cancer Wistar Institute LC-MS
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Brain Mouse Cancer Wistar Institute LC-MS
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Heart Mouse Cancer Wistar Institute LC-MS
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Liver Mouse Cancer Wistar Institute LC-MS
ST003435 AN005643 Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 Media Zebrafish Cancer Wistar Institute LC-MS
ST003434 AN005641 Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. Blood Mouse Cancer Wistar Institute LC-MS
ST003433 AN005639 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 Cultured cells Human Cancer Wistar Institute LC-MS
ST003432 AN005637 Intracellular and medium metabolomics of BT-474 cells treated with LW6 Cultured cells Human Cancer Wistar Institute LC-MS
ST003431 AN005635 Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. Cultured cells Human Cancer Wistar Institute LC-MS
ST003430 AN005633 Intracellular and medium metabolomics of BT-474 cells treated with GSK2194069 Cultured cells Human Cancer Wistar Institute LC-MS
ST003429 AN005631 Intracellular and medium metabolomics of BT-474 cells treated with Fasnall that was manufactured by Enamine Cultured cells Human Cancer Wistar Institute LC-MS
ST003428 AN005629 Intracellular and medium metabolomics of BT-474 cells treated with rotenone Cultured cells Human Cancer Wistar Institute LC-MS
ST003427 AN005627 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate Breast cancer cells Human Cancer Wistar Institute LC-MS
ST003412 AN005604 Intracellular and medium metabolomics for BT-474 cells treated with cerulenin, TVB-2640, and TVB-3166 for 24 h Cultured cells Human Cancer Wistar Institute LC-MS
ST003411 AN005602 Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h (C75 MRM included) Cultured cells Human Cancer Wistar Institute LC-MS
ST003367 AN005518 Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h Cultured cells Human Cancer Wistar Institute LC-MS
ST003366 AN005516 Malate dehydrogenase (MDH) inhibition assay: Fasnall does not affect MDH activity in vitro Synthetic Zebrafish Cancer Wistar Institute LC-MS
ST003162 AN005189 Loss of dihydroceramide desaturase drives neurodegeneration by disrupting endoplasmic reticulum and lipid droplet homeostasis in glial cells CNS Fruit fly Brain disease Washington University in St. Louis LC-MS
ST003162 AN005189 Loss of dihydroceramide desaturase drives neurodegeneration by disrupting endoplasmic reticulum and lipid droplet homeostasis in glial cells Larvae Fruit fly Brain disease Washington University in St. Louis LC-MS
ST002663 AN004335 MoTrPAC: Endurance exercise training study in young adult rats, Rat White Adipose Powder - Targeted Acyl-CoA White adipose Rat Duke University LC-MS
ST002662 AN004334 MoTrPAC: Endurance exercise training study in young adult rats, Rat Liver Powder - Targeted Acyl-CoA Liver Rat Duke University LC-MS
ST002661 AN004333 MoTrPAC: Endurance exercise training study in young adult rats, Rat Heart Powder - Targeted Acyl-CoA Heart Rat Duke University LC-MS
ST002660 AN004332 MoTrPAC: Endurance exercise training study in young adult rats, Rat Gastrocnemius Powder - Targeted Acyl-CoA Gastrocnemius Rat Duke University LC-MS
ST002505 AN004127 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST001066 AN001744 Lipidomics analysis for aged mice liver (part-III) Adipose tissue Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001066 AN001744 Lipidomics analysis for aged mice liver (part-III) Brain Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001066 AN001744 Lipidomics analysis for aged mice liver (part-III) Liver Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001066 AN001744 Lipidomics analysis for aged mice liver (part-III) Muscle Mouse Takeda Pharmaceutical Company Limited LC-MS
  logo